MedPath

Hexylresorcinol

Generic Name
Hexylresorcinol
Drug Type
Small Molecule
Chemical Formula
C12H18O2
CAS Number
136-77-6
Unique Ingredient Identifier
R9QTB5E82N

Overview

Hexylresorcinol is a substituted dihydroxybenzene. It exhibits antiseptic, anthelmintic, and local anesthetic properties. It can be found in topical applications for minor skin infections and in oral solutions or throat lozenges for pain relief and first aid antiseptic. The compound may also be used commonly in various commercial cosmetic anti-aging creams while ongoing studies research the possibility of using hexylresorcinol as an anti-cancer therapy - indications all of which require further study and testing at the current moment.

Indication

Hexylresorcinol is predominantly employed as the active ingredient in lotions, sprays, or lozenges indicated as a (a) topical antiseptic to help prevent skin infection in minor cuts, scrapes, or burns, or (b) as an antiseptic and local anesthetic for the relief of a sore throat and its associated pain . In addition, hexylresorcinol is used as an active ingredient in various commercial cosmetic skincare products as an anti-aging cream while other studies have looked into whether or not the compound could be used effectively as an anti-inflammatory agent or even as an anti-cancer therapy .

Associated Conditions

  • Mouth irritation
  • Pain, Orofacial
  • Skin Infections
  • Sore Throat

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor

No clinical trials found

No clinical trials found for this drug

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
RB Health (US) LLC
72854-262
ORAL
2 mg in 1 1
4/8/2025
RB Health (US) LLC
72854-263
ORAL
2 mg in 1 1
4/8/2025
RB Health (US) LLC
72854-261
ORAL
2.4 mg in 1 1
4/8/2025

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

Health Canada Drug Approvals

Approved Product
Company
DIN
Dosage Form
Strength
Market Date
BRONCHODEX PASTILLES ANTISEPTIQUES-S.CERISE
prodemdis enr.
02033127
Lozenge - Oral
2.4 MG / LOZ
12/31/1993
SOOTHE AID LOZ 2.4MG
zee medical
00806668
Lozenge - Oral
2.4 MG / LOZ
12/31/1995
ANTISEPTIC SORE THROAT LOZ. (LEMON FLAVOUR)
h.j. sutton industries ltd.
02227568
Lozenge - Oral
2.4 MG / LOZ
1/24/1997
BRONCHODEX PAST.ANTISEP.-S.MIEL ET EUCALYPT.
prodemdis enr.
02033771
Lozenge - Oral
2.4 MG / LOZ
12/31/1993
BRONCHODEX PAST.ANTISEPT. EXTRA FORTES-S.CER
prodemdis enr.
02031809
Lozenge - Oral
3.5 MG / LOZ
12/31/1993
BRADOSOL LOZENGES REGULAR STRENGTH 2.4MG (CHERRY, MINT, LEMON, ORANGE, HONEY-EUCALYPTUS)
columbia laboratories canada inc
00846589
Lozenge - Oral
2.4 MG
12/31/1991
SUCRETS EXTRA STRENGTH CHERRY LOZENGES
heritage brands, a subsidiary of insight pharmaceuticals llc
01951734
Lozenge - Oral
3.5 MG
1/1/1992
SUCRETS REGULAR MINT LOZ
smithkline beecham consumer healthcare, division of smithkline beecham inc.
01951793
Lozenge - Oral
2.4 MG / LOZ
12/31/1993
ANTISEPTIC THROAT LOZENGES (WITH HEXYLRESORCINOL)
h.j. sutton industries ltd.
02228432
Lozenge - Oral
2.4 MG
1/3/1997
LEMON MENTHOL ANTISEPTIC THROAT LOZ 2.4MG
ksl pharmaceuticals
01996851
Lozenge - Oral
2.4 MG / LOZ
12/31/1994

CIMA AEMPS Drug Approvals

Approved Product
Company
Registration Number
Pharmaceutical Form
Prescription Type
Status
No CIMA AEMPS (Spain) approvals found for this drug.

Philippines FDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product
Company
Registration Number
Dosage Form
Strength
Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name
MA Holder
MA Number
Pharmaceutical Form
Active Ingredient
Authorization Date
No UK EMC drug information found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.